Epitalon Research Review: The Telomerase Paper, the Mouse Data and the Gaps

Epitalon is one of the shortest molecules in the catalogue and one of the most heavily discussed, which is an unusual pairing. Most of that discussion traces back to a small number of papers from a single research group. This review of epitalon research walks through those papers in the order a reader evaluating the compound would want: what the molecule is, what each key study measured and in which model, and where the record runs out. It is a literature review, not a guide to using the compound.
What epitalon is
Epitalon (also written Epithalon) is the synthetic tetrapeptide Ala-Glu-Asp-Gly, often abbreviated AEDG. According to the 2025 review by Araj et al., 2025, it was modelled on the amino acid composition of epithalamin, an extract of bovine pineal gland. That origin matters for reading the literature: epithalamin is a mixture from tissue, and epitalon is a single defined sequence. Findings for one are not findings for the other.
At four residues, two of them acidic (glutamate and aspartate), epitalon is small, polar and carries a net negative charge near neutral pH. Its molecular mass is about 390 Da. It belongs to the family of short "bioregulator" peptides associated with Vladimir Khavinson's group in St. Petersburg, which we cover as a group in bioregulator peptides: what the research shows.
Epitalon research, study by study
2003: telomerase activity in cultured fibroblasts
The paper most often cited (Khavinson, Bondarev and Butyugov, 2003) reported that epitalon was associated with induction of telomerase activity and telomere elongation in human fetal fibroblasts in culture. It is a short report in Bulletin of Experimental Biology and Medicine. Three features shape how much weight it can bear. It is one cell-culture study. The cells are fetal fibroblasts, a specific and proliferative model. And telomere length in a dish is a cellular readout, not an organism-level outcome. The secondary literature tends to treat this paper as a mechanism; the paper itself is a single observation, and the sources reviewed here do not document independent replication.
2003: biomarkers, lifespan and tumour incidence in mice
The second key paper (Anisimov et al., 2003) followed female Swiss-derived SHR mice and measured biomarkers of ageing, lifespan and spontaneous tumour incidence. On lifespan, the study found no change in mean lifespan, while the survival of the longest-lived animals was longer in the treated group. That distinction is the single most important detail in the file and is routinely lost in summaries: an effect confined to the tail of a survival curve in one mouse strain is a much narrower result than a shift in average survival. Tumour incidence was a separate endpoint; readers interested in it should go to the paper itself rather than to secondary accounts.
Pineal, melatonin and antioxidant reports
Because of its pineal-extract lineage, epitalon has been studied for neuroendocrine effects. The Araj review describes reported effects on melatonin synthesis and on several enzymes, and reported antioxidant activity in laboratory models. It also notes that it remains unclear whether any of these explains the compound's reported actions.
2025: the current overview
The 2025 review is the best single entry point. It collects in vitro, in vivo and in silico work, and its own conclusion is that the mechanism is not established. That is a useful anchor: the most recent comprehensive review does not claim more than the primary data support.
Where the evidence stops
- Model ceiling. The evidence is largely cell culture and rodents. Controlled human trials of the synthetic tetrapeptide are lacking.
- Source concentration. Much of the primary work comes from one group and its collaborators. That does not make it wrong, but independent replication is the step the file is missing.
- Extract versus peptide. Some human data quoted in secondary sources concern the pineal extract epithalamin, sometimes combined with other preparations, not epitalon. Those should not be read as epitalon data.
- Mechanism open. Telomerase, melatonin and antioxidant findings are reported associations. None has been shown to be the cause of the in vivo observations.
The fair summary: a defined, easily characterised tetrapeptide, an intriguing but single fibroblast telomerase report, one mouse study with a tail-of-the-curve survival finding and no change in mean lifespan, and an open mechanism.
Characterising a four-residue peptide
Very short peptides are easy to synthesise and surprisingly easy to get subtly wrong. Epitalon is polar and elutes early on reverse-phase HPLC, so a method has to retain it well enough to separate it from synthesis by-products such as truncated or deletion sequences. Mass spectrometry confirms the expected mass of about 390 Da.
There is one sequence-specific point worth knowing. The Asp-Gly junction at the C-terminal end is a classic site for aspartimide formation during synthesis and for isomerisation to isoaspartate during storage. Isoaspartyl variants have the same mass as the intended peptide, so mass spectrometry alone cannot exclude them; chromatographic separation is what reveals them. That is one reason a certificate showing both an HPLC trace and a mass result is more informative than either alone. Each lot's certificate states its measured purity and identity, and the catalogue item is stored at −20 °C, desiccated, which slows these moisture-driven reactions.
Specification
| Field | Value |
|---|---|
| Catalogue name | Epitalon |
| Sequence | Ala-Glu-Asp-Gly (AEDG) |
| Also known as | Epithalon |
| Category | Bioregulators |
| Format | Lyophilised powder, glass vial, crimp seal, flip-top cap |
| House code | CS-EPI-10 (10 mg) |
| Storage | −20 °C, desiccated |
| Lot documentation | RP-HPLC identity and measured purity, mass confirmation, per lot |
| Evidence stage | Mostly preclinical (cell and rodent) |
For other compounds whose literature is dominated by cell and rodent work with an open mechanism, see our humanin research review and NAD+ research review.
Frequently asked questions
What is the epitalon sequence?
Ala-Glu-Asp-Gly, a synthetic tetrapeptide often written AEDG. It was modelled on the amino acid composition of epithalamin, a bovine pineal extract.
Did epitalon extend lifespan in mice?
In the 2003 SHR mouse study, mean lifespan did not change; the survival of the longest-lived animals was longer. It is one study in one strain, and it is commonly overstated in secondary sources.
Is the telomerase finding established?
It rests mainly on a single 2003 cell-culture report in human fetal fibroblasts. The 2025 review describes the mechanism as not established.
Why does the certificate need an HPLC trace as well as a mass?
Because isoaspartate variants that can form at the Asp-Gly junction have the same mass as the intended peptide. Only chromatographic separation distinguishes them.
See it in the catalogue: Epitalon.
For laboratory research use only. Products sold by California Standard Peptides are not drugs, foods, supplements or cosmetics and are not for human or veterinary use. This article summarises published literature; it is not medical advice and not a usage guide.